Evonik in Singapore

Today, Singapore is the regional headquarters and Innovation hub for the region. Supplying and producing locally, we are constantly stepping up our presence to strengthen the competitiveness of our customers through research and applications.

In Singapore, our manufacturing assets include the world’s largest production complex for essential amino acid DL-methionine within the Evonik network and an oil additives production site on Jurong Island. It also includes two manufacturing facilities in Tuas, with one producing Epoxy Curing Agent, Ink & Hotmelt Resin and Polyurethane Catalyst Blends, and another catalyst recovery center.

As a leading global supplier of high performance VISCOPLEX® lubricant additives and VISCOBASE® synthetic base fluids for the automotive and industrial lubricants, Evonik opened its Oil Additives plant on Jurong Island in 2008. We nearly doubled the production capacities in 2015, making it our largest Oil Additives production site in our global network.

In 2014, Evonik opened a world-scale production complex for MetAMINO®, the essential amino acid DL-methionine used in sustainable animal feed. To better serve the strong demand from customers in Asia, Evonik expanded its operations in 2019 by opening a second complex for DL-methionine adjacent to the existing plant. With the completion of a plant expansion and upgrade in 2024, the methionine complexes in Singapore have been enhanced to reduce the product's carbon footprint, allowing the company to supply approximately 340,000 metric tons of MetAMINO® from Singapore to businesses worldwide.

The catalyst recovery center was acquired in 2020 as part of Evonik's growth strategy. It has activities in the field of desulfurization catalyst rejuvenation, sulfur recovery catalysts and alumina based purification adsorbents, which contributes to Evonik's focus on sustainability and the transition to a circular economy.

Singapore is also home to our Research and Development (R&D) hub in the region including our innovation and technical service centers. Our Asia Research Hub in Singapore internationalizes research to develop next generation solutions for sustainability, including in the areas of cell culture solutions, skin biology, functional surface and coating as well as process innovation. Since its inception in 2018, the Hub has continued its expansion to create sustainable solutions based on customers’ needs. With the opening of Life Science & Advanced Biomedical lab expansion in 2022 and a new global institute dedicated to skin sciences in 2024, Evonik is dedicated to deliver cutting-edge products whilst build a better, more sustainable future for generations to come.